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Annamaria Iagnocco, MD, Fulvia Ceccarelli, MD, Carlo Perricone, MD, and Guido Valesini, MD
Sensitive imaging tools are needed to assess disease activity, to detect joint damage, to
monitor treatment response, and to predict disease outcome in rheumatic diseases. For its
advantages in costs and risks, and for its validity, reproducibility, and sensitivity to change,
ultrasonography (US) is playing an increasing role in the evaluation of joints in patients with
inflammatory and degenerative disorders. US has demonstrated to be sensitive in the
detection of early bone erosions as well as in the depiction of soft-tissue damage.
Semin Ultrasound CT MRI 32:66-73 © 2011 Elsevier Inc. All rights reserved.
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tThe need of early suppression of inflammation, to preventpersistent damage, determined the development of sen-
sitive imaging techniques able to detect early signs of disease
activity and damage. In this regard, ultrasonography (US) is
playing an increasing role in the evaluation of joints with
inflammatory and degenerative processes. In the last decade,
the use of US, characterized by several advantages, such as
limited cost, minimal risk to patient safety, good reproduc-
ibility, and sensitivity to change, superseded commonly used
imaging modalities, such as plain radiography (X-ray) and
even more sophisticated tools, such as computed tomogra-
phy (CT), in the assessment of patients affected by rheumatic
diseases.1
Radiographic investigation can document a wide range of
changes, according to the stage and severity of the illness.
Indeed, in the early stages of rheumatoid arthritis (RA), ra-
diographic findings include soft-tissue shadowing around
joints (in the hands and feet), juxta-articular osteopenia, and
loss of joint space linked with focal eburnation of articular
cartilage.2 However, radiography is an insensitive tool for the
etection of early bone erosions compared with US.3 Osteo-
arthritis (OA) has been traditionally imaged by the use of
conventional radiography: common radiological findings of
OA are represented by joint space narrowing, osteophytes,
sclerosis, and deformity. However, this technique has evident
limitations in imaging hyaline cartilage and soft tissues,
which are frequently involved with disease progression over
the years.4
Magnetic resonance imaging (MRI) has been recently, and
successfully, used in the management of rheumatic diseases.
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doi:10.1053/j.sult.2010.11.004This technique offers several advantages, such as 3-dimen-
sional or tomographic viewing perspective, availability of
cross-sectional images of the anatomy in any given plane and,
overall, the visualization of all the joints structures, included
bone marrow. The use of MRI in patients with RA clearly
demonstrates soft-tissue changes of synovium and surround-
ing tissue as well as erosive bony changes, with an excellent
correlation between histomorphologic changes of inflamed
joints and the MRI findings. The use of this technique re-
quires enhancement with intravenous gadolinium to demon-
strate synovitis. Therefore, a pre- and post-gadolinium en-
hancement T-weighted scan is performed together with a
T2-weighted fat-saturated sequence to permit accurate de-
scription of bone edema and erosive changes in RA patients.
The Outcome Measures in Rheumatology (OMERACT)
group has adopted a semiquantitative system to score bone
changes by MRI in RA.5 This score system has been shown to
e sensitive to change at all stages of the disease, especially in
elation to the progression of erosive changes evaluated by
tandard radiography. Nonetheless, the use of MRI in pa-
ients affected with RA showed some limitations, including
ifficult access to scanners in some centers together with the
igh costs and limited feasibility for the follow-up.
CT scanning is rarely used in clinical practice to image
atients with rheumatic diseases. Because of its accuracy in
etecting bony erosions in RA patients, it has been used as the
old standard imaging tool for the quantification of bone
rosions. However, CT is less accurate than US and MRI in
emonstrating soft-tissues changes.6 In the recent years, the
se of US has been introduced into the daily routine clinical
ractice in rheumatology. US technique includes grayscale
maging of anatomic structures and blood flow detection
ith the usage of the Doppler modalities. These are based on
he variations of the frequency of a sound beam reflected to
he source when it encounters a moving particle. Thus, US
ecame an established imaging technique in the evaluation of
a
t
z prob
Role of ultrasound in rheumatology 67peri- and intra-articular structures, providing an accurate de-
piction of soft tissue and bony cortex changes at all stages of
the disease. Nonetheless, US showed correlation with clinical
and laboratory data.7-10 In 2005, the OMERACT US group
published consensus US definitions for common pathologic
lesions observed in patients with inflammatory arthritis. In
particular, synovial fluid was defined as an abnormal hy-
poechoic or anechoic intra-articular material that is displace-
able and compressible, and that does not exhibit Doppler
signal; synovial hypertrophy as an abnormal hypoechoic in-
tra-articular tissue that is nondisplaceable and poorly com-
pressible and that may exhibit Doppler signal; tenosynovitis
as hypoechoic or anechoic thickened tissue with or without
fluid within the tendon sheath that is seen in 2 perpendicular
Figure 1 Representative images of OMERACT definiti
proceeding clockwise. (A) Grayscale anterior para-patel
effusion (*). (B) Posterior medial longitudinal scan of the
the presence of Doppler signal (arrowhead). (C) Anter
showing the presence of anechoic fluid within the ten
tenosynovitis. (D) Dorsal longitudinal scan at the II met
intra-articular discontinuity of the bone surface. (E) Pos
hypoechoic and thickened Achilles tendon (O) at its bo
presence of Doppler signal (arrowhead) and bone erosio
the presence of hypoechoic material (*) within the tend
(arrowhead) as for tenosynovitis. Note: for Figs. 1-4, ima
(Esaote, Genoa, Italy) equipped with 4-13 and 6-18 MHplanes, and that may exhibit Doppler signal; enthesopathy as ian abnormally hypoechoic (loss of normal fibrillar architec-
ture) and/or thickened tendon or ligament at its bony attach-
ment seen in 2 perpendicular planes, that may exhibit Dopp-
ler signal and/or bony changes, including enthesophytes,
erosions or irregularity; finally, bone erosion as an intra-
articular discontinuity of the bone surface that is visible in 2
perpendicular planes.11 Representative images are shown in
Figure 1.
Comparison studies between US and other imaging tech-
niques, such as MRI, arthroscopy, scintigraphy, and ther-
mography, confirmed the validity of sonography in the de-
tection of synovial inflammation,12 which is more specifically
nd sensitively recognized since the development of Doppler
echnologies.13,14 These techniques, in fact, are able to assess
US common pathologic findings. From the top left
itudinal scan of the knee showing the presence of local
howing synovial hypertrophy (*) in a Baker’s cyst. Note
sverse scan in neutral position at the bicipital groove
eath of the long head of the biceps tendon (O) as for
l head showing the presence of a bone erosion (*) as an
longitudinal scan at the heel showing the presence of a
chment on the calcaneus as for enthesopathy. Note the
(F) Volar longitudinal scan at the carpal tunnel showing
eath of the flexor digitorum that shows Doppler signal
re obtained by the use of theMyLab 70 XVisionmachine
es. (Color version of figure is available online.)ons of
lar long
knee s
ior tran
don sh
acarpa
terior
ny atta
ns (*).
on sh
ges wenflammatory activity both in early disease, when pathologic
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68 A. Iagnocco et alchanges may be more subtle, and in established disease,
when chronic synovial hypertrophy may be present. Simi-
larly to MRI, semiquantitative scoring systems also have been
developed for US. Themost commonly used ranges from 0 to
3 according to the severity of the alteration, being 0 absent,
1  mild, 2  moderate, 3  severe. This score is usually
alculated for each variable analyzed (synovial fluid, synovial
ypertrophy, Doppler signal) and has been applied even in
he monitoring of response to treatment with encouraging
esults.
US in Rheumatoid Arthritis
US can be usefully applied in the assessment and monitoring
of RA. As demonstrated by several studies, the sensitivity of
traditional methods in the detection of signs of inflammation
can be improved by US. Evaluation of the metacarpophalan-
geal (MCP), proximal interphalangeal (PIP), and metatarso-
phalangeal (MTP) joints can be particularly useful in patients
with early and established disease.9,15,16 In presence of syno-
ial thickening, the application of power Doppler (PD) and
olor Doppler techniques can help in differentiating between
ctive and inactive inflammation. Short-term follow-up stud-
es demonstrated a correlation between disease activity and
he degree of synovial inflammation documented in both
ray scale and PD modalities.17-20 Concerning the US evalu-
tion of bone erosions, in 1999 Backhaus and colleagues9
found that this technique can visualize more erosions than
radiography in RA. This evidence was further confirmed
whenMRI or CTwas used as the referencemethod, especially
in patients with early disease.15,16,21
Several research groups have evaluated the role of US in
the monitoring of the response to treatment in RA patients.
Filippucci and colleagues22 showed significant decrease in
oint cavity widening after intra-articular steroid administra-
ion in the small joints of the hands and feet of 20 mostly RA
atients. These results have been confirmed by Terslev and
oworkers23 who, in a study of 51 RA patients treated with
ntra-articular steroids, showed a decrease of 31% of the pre-
reatment area of the synovial membrane displayed on gray-
cale ultrasound. Moreover, color Doppler signal before and
fter intra-articular steroid treatment was evaluated by New-
an, and colleagues who described a decrease in synovial
erfusion in the knees of 8 RA patients.24 Administration of
umor necrosis factor alpha (TNF-)blocking agents re-
sults in significant decrease of vascularization evaluated with
PDUS. Hau et al25 published a study in which they used PD
on the MCP joints of 5 RA patients treated with etanercept
and demonstrated a significant decrease of the number of
color signals per region of interest after only 1 month of
follow-up. A reduction in the signs of synovitis by grayscale
and Doppler was shown in the hands and wrists of patients
with RA treated with infliximab or etanercept.23,26 We eval-
ated the response to etanercept and adalimumab in RA pa-
ients, showing that treatment efficacy was followed by im-
rovement of US findings with correlation with disease
ctivity indexes.27,28Few studies confirmed the role of US in determining the
prognosis of RA patients. Taylor and coworkers29 published
ata on 24 patients with early RA treated with methotrexate
lus either placebo or infliximab showing that changes in the
ynovial thickening and joint vascularity measured with Dopp-
er technique in the MCP joints at baseline may predict the
agnitude of radiographic changes after 2 years. A study by
aredo and colleagues,30 in 42 early RA patients starting dis-
ase-modifying antirheumatic drugs, showed a positive correla-
ion between time-integrated values of PD parameters and clin-
cal activity, expressed with the Disease Activity Score-28
DAS28). Furthermore, US showed positive correlation with
adiographic progression. Another study by the same group on
78 RA patients treated with TNF-–blocking agents showed
that PD is prognostic for the level of clinical activity and predic-
tor of progression of the total radiographic score.31 Brown and
coworkers32 analyzed a cohort of 102 RA patients with subclin-
ical disease activity and showed that the presence of synovial
hypertrophy and PD signal in the MCP joints is predictive of
radiographic deterioration. On the basis of the results of the
existing studies, it is possible to conclude that PD and, to a
smaller extent, gray-scale synovial thickening assessment, may
be predictive of radiographic damage in course of RA.
RA patients show a typical polyarticular involvement,
whose evaluation may be time-consuming in daily practice.
However, there is not enough evidence showing which joints
and synovial recesses are best predictors of disease outcome
and response to treatment. An increasing number of studies
focused on the assessment of the validity of PDUS in the
evaluation of inflammatory activity in selected RA joints.
Scheel et al33 suggested that in patients affected with RA, US
xamination can be simplified by focusing on the palmar side
f the fingers’ joints with a semiquantitative grading of the
I-IV MCP and PIP joints (“sum of 3 fingers” method). Na-
edo and colleagues34 evaluated 94 RA patients with PDUS
nd proposed a 12-joint evaluation method (including bilat-
ral wrists, second and third MCPs, and second and third
IPs of hands and knee joints) that may be a useful tool in the
ssessment of overall joint inflammatory activity in RA. More
ecently, 160 patients with active RA starting a biological
gent underwent US examination with PD of 128 synovial
ites in 44 joints.31 By using a semiquantitative grade ranging
rom 1 to 3 in all the synovial sites, the authors found a highly
ignificant correlation between PDUS score and the selec-
ed count and index for synovitis. This result was maintained
hen only 24 synovial sites at 12 joints were considered
bilateral elbow, wrist, second and third MCP, knee, and
nkle joints), with similar significant correlations with
AS28.31 More recently, Backhaus and colleagues35 pro-
posed a US score based on the evaluation of the wrists, II and
III MCPs and PIPs, II and V MTPs joints of the clinically
dominant hand and foot. Synovitis and synovial/tenosynovial
vascularity are scored semiquantitatively (grade 0–3) by
grayscale and PD. The application of this score, named the
German US7 score, was a feasible tool in the examination of
patients with arthritis in daily rheumatologic practice and it
seems to significantly reflect therapeutic response.
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Role of ultrasound in rheumatology 69US in
Spondyloarthropathies
and Polymyalgia Rheumatica
US was applied not only in the evaluation of RA patients but
also in the assessment of other inflammatory diseases, such as
spondyloarthropathies (SpA) and polymyalgia rheumatica
(PMR).
A growing number of papers investigated the diagnostic
potential of US in the assessment of patients with psoriatic
arthritis (PsA), supporting its higher sensitivity compared
with clinical examination in the evaluation of synovitis, en-
thesitis, and tenosynovitis. The US findings detected in PsA
patients are similar to those found in patients with other
inflammatory conditions, such as RA. Information about the
activity of the disease can be obtained by the evaluation of the
joint effusion, synovial proliferation, synovial hyperemia and
modifications of the bone surface.
US is very sensitive in the assessment of tendon involve-
ment by its detection of exudative or proliferative tenosyno-
vitis, loss of “fibrillar” echotexture, and partial or complete
tear. The “dactylitis,” a common feature of PsA, can be well
evaluated with US. It is possible to detect a variable combi-
nation of abnormalities, such as tenosynovitis of the finger or
toe flexor tendons, synovitis (mainly distal and PIP joints),
and diffuse soft-tissue edema. Entheses can be assessed by US
in patients affected with SpA. In the early stages of the dis-
ease, the entheses and the adjacent structures may show
several morphostructural changes as entheseal thickening,
hypoechogenicity, and fibrillar separation caused by intra-
tendineous edema, with or without bursitis and different pat-
terns of PD signal distribution. In the late stages, bony cortex
changes may be related to the presence of enthesophytes
and/or bone erosions.36 Recently, Gutierrez et al37 conducted
n interesting ultrasonographic study to evaluate the inci-
ence of subclinical enthesitis in patients affected with pso-
iasis without joint involvement. One third of the examined
ntheses had signs of enthesopathy in gray-scale, 0.9% en-
heses showed PD signal. We analyzed the role of US in the
ssessment of sacroiliac joints, frequently involved in SpA
atients, and found encouraging results.38 As for RA, US was
used in the monitoring of the response to treatment of pa-
tients affected with SpA. Several reports showed a correlation
between clinical and ultrasonographic findings.39,40
US can be used to depict characteristic pathologic findings
of shoulders and hips in patients affected with PMR, thus
proving helpful in differential diagnosis with other diseases
with similar clinical features. Typical findings include gleno-
humeral joint synovitis, subdeltoid bursitis (Fig. 2), and bi-
ceps tendon tenosynovitis in the shoulders and joint synovi-
tis and trochanteric bursitis in the hips. Still, there is the need
to standardize the examination and to assess the interob-
server agreement in distinguishing lesions typical of PMR.41
Cantini and coworkers42 performed a case-control study on
7 consecutive patients with PMR and 114 control patients
ith bilateral shoulder pain and stiffness attributable to other
onditions, such as RA, PsA, SpA, OA, fibromyalgia, or con- cective tissue disease. The authors detected bursitis in all
atients, and glenohumeral synovitis and biceps tendon te-
osynovitis in 88% of the cases. An interesting study was
onducted by Zaccaria et al,43 who included 23 patients with
atypical PMR (with normal erythrocyte sedimentation rate),
and 88 patients with standard symptomatic PMR. The pa-
tients underwent shoulder US scans before receiving steroid
therapy and 90% of them showed signs of bilateral subdel-
toid bursitis. This result supports the usefulness of US in
patients with clinical signs of PMR but normal erythrocyte
sedimentation rate and its help in rendering a diagnosis.
US in
Crystal-Related Arthropathies
US is successfully used in patients affected with crystal-re-
lated arthropathies (CA), a group of disorders in which many
different species of crystals can be deposited in articular and
periarticular tissues, resulting in inflammation and damage.
US can detect joint effusion and synovial proliferation,
whereas PD can records increased tissue signal, adding infor-
mation on the inflammatory status of the anatomic struc-
tures. Bone erosions, tendinopathy, cartilage involvement,
and bursitis are frequently imaged in CA. Nevertheless, there
are some ultrasonographic features that could help in the
differential diagnosis of CA. Indeed, 3 studies highlighted the
main US features of gouty arthritis. Grassi and colleagues44
assessed 26 patients with crystal-proven gout and described
the spectrum of abnormalities observed. These included the
deposition of monosodium urate crystals on the surface of
articular cartilage (“double contour” sign), the presence of
aggregates of different shapes, echogenicity in the synovial
fluid, the deposition of crystals within tendons and the
appearance of the tophi. More recently, Thiele and
Schlesinger45 studied 37 joints of 23 patients affected by
out, observing in 92% of the patients (and in none of the
Figure 2 Anterior transverse scan in neutral position at the bicipital
groove showing the presence of hypo/anechoic material within the
subdeltoid bursa in a patients with PMR as for subdeltoid bursitis
surrounding the long head of the biceps tendon (O).ontrols) the irregular band over the superficial margin of the
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70 A. Iagnocco et alarticular cartilage of the metatarsal and metacarpal heads,
femoral condyles and humeral head (“double contour” sign).
In all the MCP and MTP joints, tophaceous material was
shown together with erosions that were frequently adjacent
to the tophaceous material. Furthermore, synovial hypertro-
phy was imaged as a concentric thickening of the synovial
membrane. Interestingly, Wright et al46 found that US is
ore effective than plain radiographs in the detection of bone
rosive damage in the first MTP joint in patients affected by
out. Bone erosions were detected also in joints in which
linical gouty attacks had never occurred. PD has demon-
trated increased perfusion in approximately 79% of the
oints from gouty patients.47 The decrease of the signal was
obtained after colchicine therapy.48 US was reliable in the
measurement of tophi in chronic gouty patients, showing a
good sensitivity to change, associated with urate-lowering
therapy, and a good intraobserver correlation at follow-up.49
US is effective also in demonstrating calcium pyrophos-
phate deposits in chondrocalcinosis (CPPD). In 1995, Coari
et al50 showed the presence of calcification within condylar
artilage in 43 knees of 28 patients with CPPD, results con-
rmed by Foldes51 and lately by Sofka et al,52 who described
case of US-detected meniscal calcification not visualized by
onventional radiography. The US criteria for the diagnosis
f CPPD deposition were proposed by 2 distinct groups:
rassi et al44 focused their attention on the different pattern
f crystal deposition in gout and CPPD disease, showing that
he presence of hyperechoic material within the substance of
yaline cartilage is typical of chondrocalcinosis. Frediani et al
tudied the relation and relationships between the presence
f such crystals in articular and periarticular structures and
he presence of crystals in the synovial fluids of patients with
S evidence of CPPD deposition. They compared US with
adiography and found that US was superior in the identifi-
ation of pyrophosphate crystals.53 The Achilles tendon and
the plantar fascia of patients with proven (radiographic or
microscopic evidence) CPPD disease may show abnormali-
Figure 3 Differential diagnosis between gout and CPP
deposition of monosodium urate crystals on the surfa
(arrowhead). Note the presence of bone erosions (arro
Posterior lateral longitudinal scan of the knee showing th
femoral hyaline cartilage layer in CPPD (F, femur).ties in calcifications (detected in 57.9% of the Achilles ten-dons and in 15.8% of the plantar fascia) as described by
Falsetti et al.54 The US features observed included multiple
thin linear bands and dishomogeneous rounded hyperechoic
deposits. Plantar fascial calcification was always present as a
single fine linear echoic band in the superficial region of the
insertional tract, apparently not in contiguity with the corti-
cal bone. Interestingly, the authors observed that there were
no acoustic shadows behind the calcifications, probably be-
cause CPPD crystal deposits in the tendons are unstructured
and allow US penetration.55 Representative images of com-
parison between CPPD and gout are shown in Fig. 3.
US in Degenerative
Rheumatic Disease
OA is the most widely studied degenerative disease with US.
Indeed, conventional radiography has played an important
role in the past in confirming the diagnosis of OA and in the
monitoring of the disease progression. This imaging tech-
nique is able to directly visualize bone features of OA, includ-
ing marginal osteophytes, subchondral sclerosis, and sub-
chondral cysts. However, the assessment of joint space
provides only an indirect estimate of cartilage thickness and
meniscal integrity. The radiographic definition of OA is de-
pendent from the evaluation of marginal osteophytes and
joint space narrowing. The progression of joint space nar-
rowing is the most commonly used criterion for the assess-
ment of OA outcome and its complete loss, with the bone-
on-bone contact, is one of the factors considered in the
decision for joint replacement. The severity of OA can be
estimated with the use of semiquantitative scoring systems.
Several grading scales incorporating combinations of features
also have been developed, including the most widely used,
the Kellgren and Lawrence grade classification. In contrast,
the OsteoArthritis Research Society International atlas classi-
fication grades separately the tibiofemoral joint space nar-
Medial longitudinal scan of the elbow showing the
he articular cartilage (“double contour” sign) in gout
low a massive tophus (*) (H, humerus; U, ulna). (B)
ence of deposition of pyrophosphate crystals within theD. (A)
ce of t
w) be
e presrowing and osteophytes in each compartment of the knee.55
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Role of ultrasound in rheumatology 71CT is a valuable additional imaging tool when used for the
detailed imaging of the osseous changes and the presurgical
planning. Besides this, in routine clinical setting, CT plays a
minor role as drawbacks of CT are low soft tissue contrast
and exposure of patients to ionizing radiation. Nevertheless,
OA affects the whole joint, including cartilage, bone, and
intra- and periarticular soft tissues that could be detected
only indirectly by radiography and CT.56
Although capable of detecting early changes of OA, MRI
rarely is used in the routine assessment or initial diagnosis.
Compared with radiography, MRI offers several advantages
in the imaging of OA being uniquely able to directly depict all
anatomic structures of the joint, including the articular car-
tilage, menisci, intra-articular ligaments, synovium, capsular
structures, bone contours, and bone marrow. This allows the
evaluation of the joint as a whole organ and provides a more
detailed picture of the changes associated with OA.56
In recent years US evaluation showed an increasing em-
ployment in patients affected by OA, US can detect and eval-
uate a large number of abnormalities involving hyaline carti-
lage, synovial fluid and synovial membrane, menisci, joint
capsule and bursae as well as the bony cortex. US demon-
strates a large set of changes involving the hyaline cartilage
from early to late disease. At first, the superficial cartilaginous
margins are involved with the formation of the microcleft as
Figure 4 Ultrasonographic features of OA. From upper le
of the knee showing the presence of a fluctuating calcific
shadow of the calcification, which was bigger than 10 m
presence of large osteophytes (arrowheads) visualized b
together with the presence of calcification of the menisc
knee showing the presence of other osteophytes visuali
joint (F, femur; T, tibia). (D) Anterior suprapatellar tran
(white arrow) abnormalities with evidence of loss of
irregularities of margins and thinning of the layer till cothe result of tissue deterioration. Then, changes in the echo-texture appear, with the evidence of loss of homogeneity and
transparency. Together with disease progression, focal and
asymmetric narrowing are usually present and diffuse thin-
ning is charted up to the complete absence of the cartilagi-
nous layer that corresponds to cartilage breakdown and bony
denudation (Fig. 4). Cartilaginous changes need to be as-
sessed by correct US scanning technique, based on appropri-
ate patient positioning, adequate probe location, to obtain
perpendicular “insonation” of the US beam, and assessment
of the controlateral site to perform complete and deep com-
parison.56 Moreover, US can be used to assess bony surface
bnormalities. Osteophytes are imaged as cortical protru-
ions at the joint margin seen in 2 perpendicular planes and
isualized as either proximal or distal to the joint. They usu-
lly have a posterior acoustic shadow. In erosive hand OA,
rosions are imaged as a cortical breakage with a step-down
ontour defect, seen in 2 planes. The detection of erosions
ay be difficult because of the interposition of osteophytes,
hich may determine narrowing of the acoustic window. In
study conducted by our research group, 22 patients with
adiographic signs of erosive OA were enrolled, showing that
entral erosions were detected by US in 72.7% of patients,
ith a sensitivity and specificity for the detection of central
rosions by US of 73% and 100%, respectively.57
In OA patients with synovitis, joint effusion with synovial
eeding clockwise. (A) Posterior lateral longitudinal scan
arrowhead) within a Baker’s cyst (O). Note the acoustic
. (B) Medial longitudinal scan of the knee showing the
ximal (femoral side) and distal (tibial side) to the joint,
(F, femur; T, tibia). (C) Lateral longitudinal scan of the
th proximal (femoral side) and distal (tibial side) to the
scan of the knee showing the femoral hyaline cartilage
e anechoic echostructure, loss of margins sharpness,
disappearance (arrowhead).ft proc
ation (
m (*)
oth pro
us (*)
zed bo
sverse
cartilagthickening and proliferation may appear and can be detected
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72 A. Iagnocco et alby grayscale US. In presence of active inflammation, Doppler
modalities are able to demonstrate increased local vascular-
ization within the synovial tissue. OMERACT definitions for
synovial fluid and synovial hypertrophy in RA can be applied
in OA as well. US is able to identify even minimal joint effu-
sion, which can be either anechoic or inhomogeneously hy-
poechoic, depending on its composition and on the presence
of intra-articular debris and proteinaceous or calcified mate-
rial. Synovial hypertrophy is another frequent finding in in-
flamed osteoarthritic joints. In patients with knee OA, US
scans over the medial aspect of the joint, frequently demon-
strate protrusions of the medial meniscus with displacement
of the medial collateral ligaments. To complete US evaluation
of osteoarthritic joints, analysis of peri-articular areas, where
abnormalities may be occasionally found, is necessary. Typ-
ically, those changes consist on the appearance of bursitis
that is imaged by US with the representation of abnormal
hypo-anechoic, displaceable and compressible intrabursal
material. They usually involve the local bursae of the knee,
with the appearance of Baker’s cysts and anserine bursitis.
Also the feet can be affected with the demonstration of bur-
sitis over the medial aspect of the first MTP joint. Several
papers showed that US can be applied in the monitoring of
the response to treatment with hyaluronic acid in patients
affected with OA.58,59 Recently, we described the employ-
ent of US in the assessment of 53 patients with primary
ymptomatic knee OA treated for 12 consecutive days with
ocally applied mud-packs. We observed a significant im-
rovement of the US findings evaluated with a semiquantita-
ive score, that correlated with clinical and laboratory indexes
f disease activity.60
In conclusion, more work is needed to standardize defini-
tions of pathology and to demonstrate the validity of US.
There are no conclusive accepted definitions of sonographic
pathology in OA, although those for synovial hypertrophy,
synovial effusion, tenosynovitis, enthesitis and erosion devel-
oped by the OMERACT have been successfully applied in
OA. A number of scoring systems have used in OA and have
shown marked heterogeneity. These can be dichotomous,
ordinal (based on qualitative, semiquantitative or quantita-
tive domains) or continuous scales. Nonetheless, the study of
Doppler or contrast agents in OA is still lacking and there is a
paucity of demonstrations on reliability and sensitivity to
change for US in OA.61
Conclusions
As widely recognized, US can be considered the new millen-
nium stethoscope of the rheumatologist. Its capacity to be
complementary to clinic and to recognize subclinical inflam-
mation makes it a useful instrument that can help the rheu-
matologist in taking therapeutic decisions and in monitoring
response to therapy. The continuous technology improve-
ment with production of high-level equipment together with
advances in standardization of the US techniquemay bring to
the future development of new clinimetric-ultrasonographic
score indexes, based on the principle of the “physician’s in-
tention to treat.” Finally, in the next future US may become auseful imaging tool in the prediction of the response to ther-
apy, helping in the choice of the best individual treatment in
different rheumatic diseases.
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